Meridian Clinical Research — Binghamton, New York

Meridian Clinical Research is a clinical research site located in Binghamton, New York, United States 13901.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Meridian Clinical Research has participated in 6 clinical trials with 2 currently active.

Therapeutic areas: Epstein-Barr Virus Infection, COVID-19 Disease, Atherosclerotic Cardiovascular Disease.

Sponsors: ModernaTX, Inc., Bavarian Nordic, Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Meridian Clinical Research?

Meridian Clinical Research has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Meridian Clinical Research conducted?

Meridian Clinical Research has 6 clinical trials on record, with 2 currently active. Their work covers Epstein-Barr Virus Infection, COVID-19 Disease, Atherosclerotic Cardiovascular Disease.

Is Meridian Clinical Research accredited by Crixeo Health?

Meridian Clinical Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Meridian Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.